250368 Outcomes of the Connecticut Offender Reentry Program

Tuesday, November 1, 2011: 2:50 PM

Linda K. Frisman, PhD , CT Dept Mental Health & Addiction Services, Research Division MS # 14 RSD, Hartford, CT
Jeffrey Swanson, PhD , Department of Psychiatry & Behavioral Sciences, Duke University School of Medicine, Duke University, Durham, NC
Alison Gilbert, PhD , Sheps Center, UNC Chapel Hill, Chapel Hill, NC
Hsiu-Ju Lin, PhD , CT Dept Mental Health & Addiction Services, Research Division MS # 14 RSD, Hartford, CT
The CT Offender Reentry Program (CORP) was developed by the CT Department of Mental Health & Addiction Services (CT DMHAS) in 2002, with original funding from the Serious & Violent Offender Reentry Initiative from the National Institute on Justice. Since then it has served approximately 300 prisoners with serious mental illness transitioning back to the community following an extended prison stay, and is sustained through state dollars. Program participants receive pre-release skill development in skills groups, and clinicians also facilitate their transition to community mental health agencies. Using administrative data merged between CT DMHAS with information from corrections, courts, and Medicaid, we compared 1-year post-release outcomes of CORP program participants to those of a comparison sample developed through propensity matching. CORP participation resulted in reduced criminal justice involvement and reduced need for hospitalization. The CORP improves the outcomes of prisoners with mental illness being released into the community.

Learning Areas:
Public health or related research

Learning Objectives:
Identify the program components and ways a CT prison reentry program was successful in facilitating the community adjustment of prisoners with a serious mental illness

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have published extensively on this topic
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.